Pfizer Inc at Evercore HealthCONx Conference Transcript
Well, listen, thank you all for joining. It's a pleasure to have Pfizer's leadership team join us. We're going to go right into the R&D. But before we do, perhaps, let's turn it over to you, your highest priorities going into 2020 and things you're most looking forward to. And we'll jump right into it.
Yes. We were very excited about how our pipeline is projecting. Over the last number of years, we've been able to have, every year, up to 4 approvals of -- with robust drugs, and we start up to 6 pivotal studies every year. So we've been able to create a very sustainable pipeline that has close to 100 clinical projects.
Speaking particularly for now until 2020, this period, we try to summarize what you should look out for in -- that we expect to have up to 15 proof-of-concept Phase 2 data on various products that we
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
